ArQule’s Strategy
To build a leading R & D organization
using sophisticated small-molecule
chemistries, novel molecular biology,
and intelligent drug design to create
a portfolio of Optimal Chemical
Entities for oncology and inflammation
Previous slide
Next slide
Back to first slide
View graphic version